Antineoplaston A5

User Options

A Membership is required. Please Login or Create an account to get startedRequest us to build a Downloadable Document Product on this TopicMake a Request for GMI to add more Articles on this Topic Immediately (Purchase Required)View a Printer Friendly version of this pageE-mail this page to a friendPerform a Search with this Topic
Hover over an icon for more information

Additional Topics Details for this Page

  • - 1
  • - 5

View the Evidence: Substances

"Phase I clinical studies of antineoplaston A5 injections."

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:37-43. PMID: 3569014
Article Published Date : Jan 01, 1987
Study Type : Human: Case Report
Additional Links
Substances : Antineoplaston A5 : CK(3) : AC(1)
Diseases : Bladder Cancer : CK(186) : AC(60), Breast Cancer : CK(2354) : AC(621), Colorectal Cancer : CK(877) : AC(321), Lung Cancer : CK(496) : AC(198)
Pharmacological Actions : Anti-metastatic : CK(192) : AC(115), Antineoplastic Agents : CK(877) : AC(496), Chemopreventive : CK(1528) : AC(382)

Antineoplaston inhibits human breast cancer cells (HBL-100) and human leukemia cells.

Pubmed Data : Drugs Exp Clin Res. 1987 ;13 Suppl 1:31-5. PMID: 3569013
Article Published Date : Jan 01, 1987
Study Type : In Vitro Study
Additional Links
Substances : Antineoplaston A5 : CK(3) : AC(1)
Diseases : Breast Cancer : CK(2354) : AC(621), Leukemia : CK(670) : AC(258)
Pharmacological Actions : Antineoplastic Agents : CK(877) : AC(496), Antiproliferative : CK(1052) : AC(775)

Antineoplastons: history of the research (I).

Pubmed Data : Drugs Exp Clin Res. 1986 ;12 Suppl 1:1-9. PMID: 3527634
Article Published Date : Jan 01, 1986
Study Type : Review
Additional Links
Substances : Antineoplaston A3 : CK(3) : AC(1), Antineoplaston A5 : CK(3) : AC(1), Antineoplaston AS2-1 (4:1 mixture of phenylacetic acid and phenylacetylglutamine) : CK(92) : AC(1), Antineoplaston AS2-5 : CK(1) : AC(1), Antineoplastons : CK(134) : AC(36), Urine : CK(5) : AC(3)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.